Announcements Trials

Browse Landscape

Phase

Status

Completed 10 Terminated 4 Unknown 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Turcot syndrome 2 Medulloblastoma 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Rhabdoid Tumor 1 Recurrence 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Ependymoma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 13 Bevacizumab 11 Capecitabine 10 Fluorouracil 8 Blood Specimen Collection 8 Leucovorin 7 Cetuximab 7 Folfox protocol 6 pembrolizumab 5 Drug Therapy 5 trifluridine tipiracil drug combination 4 dostarlimab 4 Nivolumab 4 Irinotecan 4 HMPL-013 4 fludarabine 3 XELOX 3 Specimen Handling 3 IFL protocol 3 Cyclophosphamide 3 Biopsy 3 toripalimab 2 tislelizumab 2 tipiracil 2 regorafenib 2 pertuzumab 2 envafolimab 2 encorafenib 2 cemiplimab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colonic Neoplasms × Celecoxib × Clear all

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡